| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.04 |